Q1 Earnings Forecast for Aspen Aerogels Issued By B. Riley

Aspen Aerogels, Inc. (NYSE:ASPN) – B. Riley decreased their Q1 2025 earnings estimates for shares of Aspen Aerogels in a research report issued to clients and investors on Wednesday, February 19th. B. Riley analyst R. Pfingst now expects that the construction company will earn ($0.08) per share for the quarter, down from their prior forecast of $0.09. B. Riley has a “Buy” rating and a $22.00 price objective on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.22 per share. B. Riley also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.02 EPS and FY2025 earnings at $0.22 EPS.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%.

A number of other research firms also recently issued reports on ASPN. Barclays reduced their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research report on Wednesday. Roth Mkm reduced their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. Craig Hallum dropped their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Friday, February 14th. Finally, Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.44.

Aspen Aerogels Trading Down 1.4 %

Aspen Aerogels stock opened at $8.04 on Friday. The firm’s 50-day moving average is $11.75 and its 200-day moving average is $18.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels has a 1 year low of $7.96 and a 1 year high of $33.15. The company has a market cap of $659.27 million, a P/E ratio of 50.22 and a beta of 2.14.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently made changes to their positions in the business. Quest Partners LLC grew its stake in shares of Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after purchasing an additional 5,361 shares during the last quarter. Sandia Investment Management LP acquired a new position in shares of Aspen Aerogels in the fourth quarter worth about $89,000. Pursue Wealth Partners LLC acquired a new position in shares of Aspen Aerogels in the third quarter worth about $222,000. Mesirow Financial Investment Management Inc. acquired a new position in shares of Aspen Aerogels in the third quarter worth about $252,000. Finally, Kovitz Investment Group Partners LLC acquired a new position in shares of Aspen Aerogels in the third quarter worth about $263,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.